Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells

European Journal of Pharmacology

Volumn 603, Issue 1-3, 2009, Pages 22-28

  Sun, Yu ^a   Lu, Na ^a   Ling, Yun ^a   Gao, Ying ^a   Chen, Yan ^a   Wang, Ling ^a   Hu, Rong ^a   Qi, Qi ^a   Liu, Wei ^a   Yang, Yong ^a   You, Qidong ^a   Guo, Qinglong ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Center for Pharmacodynamics Research and Evaluation   (China)

Author keywords

Invasion; MMP 2; MMP 9; Oroxylin A

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OROXYLIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FIBRONECTINS; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; SIGNAL TRANSDUCTION;

EID: 58249104244     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.008     Document Type: Article

References (37)

1. Boucher M.J., Morisset J., Vachon P.H., Reed J.C., Laine J., and Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell Biochem 79 (2000) 355-369
2. Chen Y., Yang L., and Lee T.J. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem. Pharmacol 59 (2000) 1445-1457
3. Chen P.N., Hsieh Y.S., Chiang C.L., Chiou H.L., Yang S.F., and Chu S.C. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res 85 (2006) 220-225
4. Cortes-Reynosa P., Robledo T., Macias-Silva M., Wu S.V., and Salazar E.P. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 27 (2008) 220-231
5. Delassus G.S., Cho H., Park J., and Eliceiri G.L. New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. J. Cell Physiol 217 (2008) 739-744
6. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
7. Fang J.Y., and Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6 (2005) 322-327
8. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med 333 (1995) 1757-1763
9. Hart I.R., and Saini A. Biology of tumour metastasis. Lancet 339 (1992) 1453-1457
10. Hu Y., Yang Y., You Q.D., Liu W., Gu H.Y., Zhao L., Zhang K., Wang W., Wang X.T., and Guo Q.L. Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. Biochem. Biophys. Res. Commun 351 (2006) 521-527
11. Hwang E.S., and Lee H.J. Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells. Exp. Biol. Med. (Maywood) 231 (2006) 421-430
12. Incorvaia L., Badalamenti G., Rini G., Arcara C., Fricano S., Sferrazza C., Di Trapani D., Gebbia N., and Leto G. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res 27 (2007) 1519-1525
13. Johansson N., Ahonen M., and Kahari V.M. Matrix metalloproteinases in tumor invasion. Cell Mol. Life Sci 57 (2000) 5-15
14. Kim I.Y., Jeong S.J., Kim E.S., Kim S.H., and Moon A. Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells. J. Biochem. Mol. Biol 40 (2007) 825-831
15. Kleiner D.E., and Stetler-Stevenson W.G. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol 43 (1999) S42-S51 Suppl
16. Kubo M., Asano T., Shiomoto H., and Matsuda H. Studies on rehmanniae radix. I. Effect of 50% ethanolic extract from steamed and dried rehmanniae radix on hemorheology in arthritic and thrombosic rats. Biol. Pharm. Bull 17 (1994) 1282-1286
17. Lev D.C., Onn A., Melinkova V.O., Miller C., Stone V., Ruiz M., McGary E.C., Ananthaswamy H.N., Price J.E., and Bar-Eli M. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J. Clin. Oncol 22 (2004) 2092-2100
18. Li H.B., and Chen F. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J. Chromatogr. A 1074 (2005) 107-110
19. Liu H., Zang C., Fenner M.H., Possinger K., and Elstner E. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res. Treat 79 (2003) 63-74
20. Liu S.C., Yang S.F., Yeh K.T., Yeh C.M., Chiou H.L., Lee C.Y., Chou M.C., and Hsieh Y.S. Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin. Chim. Acta 371 (2006) 92-96
21. Lochter A., and Bissell M.J. An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases. Apmis 107 (1999) 128-136
22. Nangia-Makker P., Raz T., Tait L., Hogan V., Fridman R., and Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res 67 (2007) 11760-11768
23. Nozaki S., Sissons S., Chien D.S., and Sledge Jr. G.W. Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model. Clin. Exp. Metastasis 20 (2003) 407-412
24. Ogura S., Ohdaira T., Hozumi Y., Omoto Y., and Nagai H. Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk. J. Surg. Oncol 96 (2007) 46-53
25. Quaranta M., Daniele A., Coviello M., Venneri M.T., Abbate I., Caringella M.E., Di Tardo S., Divella R., Trerotoli P., Di Gennaro M., Schittulli F., Fransvea E., and Giannelli G. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res 27 (2007) 3593-3600
26. Saiki I., Murata J., Nakajima M., Tokura S., and Azuma I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res 50 (1990) 3631-3637
27. Sliwowska I., and Kopczynski Z. [Zymography-method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer]. Wiad Lek 60 (2007) 241-247
28. Sonoda M., Nishiyama T., Matsukawa Y., and Moriyasu M. Cytotoxic activities of flavonoids from two Scutellaria plants in Chinese medicine. J. Ethnopharmacol 91 (2004) 65-68
29. Sprague J.E., Li W.P., Liang K., Achilefu S., and Anderson C.J. In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nucl. Med. Biol 33 (2006) 227-237
30. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol 17 (2001) 463-516
31. Vincenti M.P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol. Biol 151 (2001) 121-148
32. Virtanen S.S., Vaananen H.K., Harkonen P.L., and Lakkakorpi P.T. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 62 (2002) 2708-2714
33. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13 (1999) 781-792
34. Westermarck J., Holmstrom T., Ahonen M., Eriksson J.E., and Kahari V.M. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol 17 (1998) 547-557
35. Xu L., and Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J. Biol. Chem 281 (2006) 4457-4466
36. Yoneda T., Sasaki A., and Mundy G.R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat 32 (1994) 73-84
37. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23 (2004) 101-117